Caplin Point Laboratories Market Cap

Caplin Point Laboratories has a market cap or net worth of 154.31 billion as of February 21, 2025. Its market cap has increased by 44.97% in one year.

Market Cap

154.31B

Enterprise Value

147.14B

Revenue

18.90B

Ranking

n/a

PE Ratio

29.94

Stock Price

2,029.85

Market Cap Chart

Since February 26, 2002, Caplin Point Laboratories's market cap has increased from 5.60M to 154.31B, an increase of 2,755,951.87%. That is a compound annual growth rate of 55.97%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	154.31B	-18.84%
Dec 31, 2024	190.12B	84.60%
Dec 29, 2023	102.99B	90.47%
Dec 30, 2022	54.07B	-16.82%
Dec 31, 2021	65.01B	69.50%
Dec 31, 2020	38.35B	68.44%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	3,943.91B
Divi's Laboratories	1,528.32B
Cipla	1,191.84B
Mankind Pharma	960.38B
Apollo Hospitals Enterprise	908.37B
Zydus Lifesciences	890.87B
Aurobindo Pharma	647.68B
Alkem Laboratories	550.15B

Market Cap Rankings